NCT00111644View on ClinicalTrials.gov

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Pneumonia, Bacterial
Interventions
DRUG

Ceftriaxone

1000mg iv daily

DRUG

beta-lactam

750mg iv q 23h for 3-14 days

DRUG

beta-lactam

1500mg iv q 12h for 3-14 days

Trial Locations (49)

1

Lima

11

Lima

31

Lima

1038

Riga

1180

Buenos Aires

1233

Sofia

1282

Buenos Aires

1427

Buenos Aires

1431

Sofia

1529

Budapest

1602

Buenos Aires

1606

Sofia

1657

Buenos Aires

1702

Ciudadela

1888

Buenos Aires

2045

Törökbálint

2152

Granadero Baigorria

3000

Kaunas

3100

Paraná

4400

Nyíregyháza

5000

Córdoba

5417

Daugavpils

7002

Rousse

8700

Constanța

8900

Zalaegerszeg

10000

Zagreb

21105

Bucharest

21659

Bucharest

27103

Winston-Salem

48201

Detroit

59701

Butte

70112

New Orleans

71105

Shreveport

92231

Klaipėda

200515

Craiova

07733

Holmdel

BUE1430

Buenos Aires

X5004CDT

Córdoba

S2000DSV

Rosario

Unknown

Santiago

Valdivia

Bucharest

LV-1002

Riga

08661

Vilnius

030303

Bucharest

975 17

Banská Bystrica

949 88

Nitra

950 01

Nitra

058 87

Poprad

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00111644 - A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia | Biotech Hunter | Biotech Hunter